[Federal Register Volume 61, Number 200 (Tuesday, October 15, 1996)]
[Notices]
[Pages 53761-53762]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-26320]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated June 27, 1996, and published in the Federal
Register on July 5, 1996, (61 FR 35265), Dupont Pharmaceuticals, The
Dupont Merck Pharmaceutical Company, 1000 Stewart Avenue, Garden City,
New York 11530, made application to the Drug Enforcement Administration
(DEA) for registration as a bulk manufacturer of the basic classes of
controlled substances listed below:
[[Page 53762]]
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Oxycodone (9143)............................ II
Hydrocodone (9193).......................... II
Oxymorphone (9652).......................... II
------------------------------------------------------------------------
No comments or objections have been received. DEA has considered
the factors in Title 21, United States Code, Section 823(a) and
determined that the registration of Dupont Pharmaceuticals to
manufacture the listed controlled substances is consistent with the
public interest at this time. Therefore, pursuant to 21 U.S.C. 823 and
28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office of
Diversion Control, hereby orders that the application submitted by the
above firm for registration as a bulk manufacturer of the basic classes
of controlled substances listed above is granted.
Dated: September 25, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 96-26320 Filed 10-11-96; 8:45 am]
BILLING CODE 4410-09-M